Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors

NCT00611468 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Solid Tumor

Interventions

DRUG: Topotecan
DRUG: Erlotinib

Sponsor

Accelerated Community Oncology Research Network

Collaborators

[object Object]
[object Object]